Non-invasive Coronary Imaging

Global Non-invasive Coronary Imaging Market to Reach US$530.6 Million by 2030

The global market for Non-invasive Coronary Imaging estimated at US$392.3 Million in the year 2024, is expected to reach US$530.6 Million by 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Echocardiography, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$204.8 Million by the end of the analysis period. Growth in the Cardiac Computed Tomography segment is estimated at 6.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$106.9 Million While China is Forecast to Grow at 7.9% CAGR

The Non-invasive Coronary Imaging market in the U.S. is estimated at US$106.9 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$104.0 Million by the year 2030 trailing a CAGR of 7.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 5.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global Non-Invasive Coronary Imaging Market – Key Trends & Drivers Summarized

How Is Non-Invasive Coronary Imaging Changing the Game in Cardiovascular Diagnosis?

Non-invasive coronary imaging is revolutionizing the landscape of cardiovascular diagnostics, offering clinicians safer, faster, and highly accurate methods to assess coronary artery disease (CAD) without the need for catheter-based procedures. Traditional coronary angiography, while effective, involves significant patient risk due to its invasive nature, including potential vascular injury, allergic reactions to contrast agents, and post-procedure recovery time. In contrast, non-invasive techniques such as coronary computed tomography angiography (CCTA), cardiac magnetic resonance imaging (CMR), and positron emission tomography (PET) are enabling high-resolution visualization of coronary vessels with reduced procedural risk. These technologies have become pivotal in detecting plaque buildup, assessing stenosis, and evaluating overall heart function. Patients benefit significantly from quicker turnaround times, minimal discomfort, and reduced hospital stays, while physicians gain access to detailed anatomical and functional data that supports more informed treatment decisions. Additionally, the ability of non-invasive imaging tools to detect subclinical atherosclerosis—well before symptoms appear—has made them indispensable in preventive cardiology. The integration of functional assessment through methods like fractional flow reserve derived from CT (FFR-CT) is also bridging the gap between anatomical imaging and physiological insight, allowing more accurate identification of ischemia-causing lesions. As cardiovascular disease remains the leading cause of mortality globally, the role of non-invasive imaging in early detection and disease management is only expected to grow stronger.

What Role Does Technology Play in Elevating Diagnostic Accuracy and Efficiency?

Advancements in imaging technologies are central to the growing reliability and adoption of non-invasive coronary imaging solutions. The evolution of CT scanners—marked by faster acquisition speeds, reduced radiation exposure, and improved spatial resolution—has made coronary CT angiography a frontline tool for evaluating patients with suspected coronary artery disease. Simultaneously, cardiac MRI is becoming more widely used to assess myocardial perfusion, viability, and fibrosis without exposing patients to ionizing radiation. The integration of artificial intelligence and machine learning into imaging platforms is further amplifying diagnostic accuracy, allowing for automated detection of stenosis, plaque characterization, and risk stratification based on large-scale data analysis. These technologies also streamline workflow, enabling radiologists and cardiologists to interpret scans faster and with greater consistency. Dual-energy CT and photon-counting CT are the next generation of imaging innovations, providing enhanced tissue contrast and reducing artifacts that previously hindered coronary visualization. Moreover, functional imaging techniques such as stress CMR and PET scans now offer highly precise insights into myocardial blood flow and perfusion defects, which are critical for determining the need for revascularization procedures. Interoperability with electronic health records (EHRs) and cloud-based sharing systems allows for seamless data integration and second-opinion consultations across institutions. These technological leaps are not just improving accuracy—they`re reshaping the diagnostic pathway to be faster, more patient-friendly, and highly personalized.

Are Shifting Clinical Practices and Patient Preferences Driving Adoption?

Changing clinical practices, along with evolving patient expectations, are playing a pivotal role in the increased demand for non-invasive coronary imaging modalities. Cardiologists and general practitioners are now more inclined to recommend non-invasive imaging as a first-line diagnostic option for stable chest pain and risk assessment, especially with the growing body of evidence supporting its clinical efficacy. Guidelines from prominent organizations such as the American College of Cardiology and the European Society of Cardiology increasingly favor non-invasive modalities due to their proven ability to reduce unnecessary invasive procedures and associated complications. From the patient`s perspective, the preference for non-invasive, outpatient-based diagnostics is stronger than ever, driven by a desire for convenience, lower anxiety levels, and quicker recovery. This is particularly relevant in older populations and those with multiple comorbidities, where invasive testing poses higher risks. Non-invasive options are also more scalable in telemedicine and remote healthcare models, allowing diagnostic services to be extended to patients in rural and underserved areas. Furthermore, the rising prevalence of lifestyle-related risk factors such as diabetes, obesity, and hypertension is prompting earlier and more frequent cardiovascular screening, especially in asymptomatic high-risk groups. Hospitals and imaging centers are responding to these shifts by investing in multi-modality imaging suites and expanding cardiology service lines to accommodate outpatient diagnostics. All these trends point toward a significant shift in both provider strategy and patient mindset, reinforcing the long-term adoption of non-invasive coronary imaging across healthcare systems worldwide.

What’s Powering the Rapid Growth of the Non-Invasive Coronary Imaging Market?

The growth in the non-invasive coronary imaging market is driven by several factors spanning technological innovation, evolving clinical pathways, and shifts in healthcare delivery systems. One of the foremost drivers is the advancement of imaging platforms capable of delivering detailed, real-time visualization of coronary anatomy and function without the inherent risks of invasive procedures. Continuous improvements in scanner speed, image resolution, and post-processing software have significantly broadened the clinical utility of these modalities. On the end-user side, healthcare providers are increasingly relying on non-invasive imaging to triage patients efficiently, reduce unnecessary cardiac catheterizations, and improve overall care quality. This shift is supported by updated clinical guidelines that recognize the diagnostic and prognostic value of non-invasive techniques, particularly CCTA and cardiac MRI. Consumer behavior is also influencing market dynamics, with a growing number of patients actively seeking safer diagnostic options and participating in preventive health screening programs. Additionally, the emergence of AI-enabled imaging tools has enhanced productivity, reduced diagnostic variability, and made advanced interpretation more accessible to general practitioners and non-specialist providers. Hospital networks and imaging centers are also embracing these technologies to optimize resource utilization, shorten diagnostic timelines, and improve patient throughput. Reimbursement structures in many countries are gradually aligning with these shifts, making non-invasive imaging financially viable for providers. Finally, rising cardiovascular disease prevalence across both developed and developing nations—driven by aging populations, sedentary lifestyles, and poor dietary habits—is creating a robust and ongoing demand for accurate, early-stage diagnostic tools. Together, these factors are fueling the rapid global expansion of the non-invasive coronary imaging market.

SCOPE OF STUDY:

The report analyzes the Non-invasive Coronary Imaging market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Modality (Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging, Radionuclide Cardiac Imaging); End-Use (Hospitals End-Use, Diagnostic Imaging Centers End-Use, Research Institutes End-Use)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• Abbott Laboratories
• Arterys Inc.
• Boston Scientific Corporation
• Canon Medical Systems Corporation
• Carestream Health, Inc.
• Circle Cardiovascular Imaging Inc.
• Esaote S.p.A.
• Fujifilm Holdings Corporation
• GE Healthcare
• HeartFlow, Inc.
• Hitachi Medical Corporation
• Hologic, Inc.
• NeoSoft LLC
• Neusoft Corporation
• Philips Healthcare
• Pie Medical Imaging
• Positron Corporation
• Samsung Medison Co., Ltd.
• Siemens Healthineers
• Viatronix, Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.